For the first time, WHO’s treatment tips include a clear suggestion for the use of prolonged-acting injectable cabotegravir and rilpivirine (CAB/RPV) as an alternative switching option for antiretroviral therapy (Artwork) for adults and adolescents who definitely have achieved full viral suppression on oral Artwork and don't have Energetic hepatitis B https://g.page/r/CSLr2xzoMfbHEBM